Bessemer Group Inc. Sells 8,005 Shares of Encompass Health Corporation $EHC

Bessemer Group Inc. cut its stake in shares of Encompass Health Corporation (NYSE:EHC) by 45.6% in the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 9,553 shares of the company’s stock after selling 8,005 shares during the quarter. Bessemer Group Inc.’s holdings in Encompass Health were worth $1,171,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also recently modified their holdings of EHC. Congress Asset Management Co. bought a new position in shares of Encompass Health during the second quarter valued at $92,691,000. Nuveen LLC bought a new stake in Encompass Health in the 1st quarter worth about $50,665,000. T. Rowe Price Investment Management Inc. increased its holdings in Encompass Health by 25.6% in the 1st quarter. T. Rowe Price Investment Management Inc. now owns 2,080,918 shares of the company’s stock worth $210,756,000 after buying an additional 424,691 shares in the last quarter. Strs Ohio bought a new stake in Encompass Health in the 1st quarter worth about $34,364,000. Finally, American Century Companies Inc. increased its holdings in Encompass Health by 78.6% in the 1st quarter. American Century Companies Inc. now owns 723,169 shares of the company’s stock worth $73,243,000 after buying an additional 318,251 shares in the last quarter. 97.25% of the stock is currently owned by institutional investors.

Insider Buying and Selling at Encompass Health

In other news, EVP Patrick William Tuer sold 1,020 shares of Encompass Health stock in a transaction dated Wednesday, August 27th. The stock was sold at an average price of $123.59, for a total transaction of $126,061.80. Following the transaction, the executive vice president directly owned 18,846 shares of the company’s stock, valued at $2,329,177.14. The trade was a 5.13% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. 2.00% of the stock is currently owned by insiders.

Encompass Health Trading Down 2.5%

Encompass Health stock opened at $113.86 on Friday. The business has a 50-day simple moving average of $124.22 and a two-hundred day simple moving average of $118.88. The company has a market cap of $11.47 billion, a P/E ratio of 21.52, a P/E/G ratio of 2.20 and a beta of 0.93. Encompass Health Corporation has a 52-week low of $87.85 and a 52-week high of $127.99. The company has a quick ratio of 1.06, a current ratio of 1.06 and a debt-to-equity ratio of 0.76.

Encompass Health (NYSE:EHC) last released its quarterly earnings results on Wednesday, March 16th. The company reported $0.93 earnings per share (EPS) for the quarter. Encompass Health had a return on equity of 18.19% and a net margin of 9.33%.The business had revenue of $136.30 million during the quarter. Encompass Health has set its FY22 guidance at $3.83-$4.19 EPS. Analysts predict that Encompass Health Corporation will post 4.8 EPS for the current year.

Encompass Health Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Thursday, January 15th. Stockholders of record on Friday, January 2nd will be given a dividend of $0.19 per share. This represents a $0.76 dividend on an annualized basis and a dividend yield of 0.7%. The ex-dividend date of this dividend is Friday, January 2nd. Encompass Health’s payout ratio is presently 14.37%.

Wall Street Analyst Weigh In

EHC has been the subject of several research analyst reports. Weiss Ratings reiterated a “buy (b+)” rating on shares of Encompass Health in a report on Wednesday, October 8th. Barclays lifted their price objective on Encompass Health from $141.00 to $150.00 and gave the stock an “overweight” rating in a report on Thursday. UBS Group lifted their price objective on Encompass Health from $140.00 to $150.00 and gave the stock a “buy” rating in a report on Thursday, October 2nd. KeyCorp lifted their price objective on Encompass Health from $135.00 to $140.00 and gave the stock an “overweight” rating in a report on Tuesday, September 16th. Finally, Truist Financial boosted their price target on Encompass Health from $135.00 to $140.00 and gave the company a “buy” rating in a research note on Thursday, August 14th. Two equities research analysts have rated the stock with a Strong Buy rating and eight have assigned a Buy rating to the company. According to MarketBeat, Encompass Health currently has a consensus rating of “Buy” and an average target price of $142.86.

Encompass Health Profile

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.